Hyperinsulinemia exacerbates the condition by stimulating LH receptors, inhibiting aromatase activity, and lowering sex hormone-binding globulin (SHBG) levels, thereby perpetuating the syndrome’s pathophysiology [43]. The gene discussed is CYP19A1; the disease is Hyperinsulinemia.